These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 576232)

  • 21. Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 months.
    Schwinn G; Dirks H; McIntosh C; Köbberling J
    Eur J Clin Invest; 1977 Apr; 7(2):101-7. PubMed ID: 404154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison with growth hormone responses to various drugs or substances in patients with active acromegaly (author's transl)].
    Takahara J; Ogawa N; Hosogi H; Aoki Y; Yamauchi J
    Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):803-12. PubMed ID: 821792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy.
    Hartman ML; Veldhuis JD; Vance ML; Faria AC; Furlanetto RW; Thorner MO
    J Clin Endocrinol Metab; 1990 May; 70(5):1375-84. PubMed ID: 2335577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of CB-154 therapy on the glucose tolerance, IRI and GH response to glucose administration in acromegaly.
    Demura R; Yamaguchi H; Demura H; Shizume K
    Endocrinol Jpn; 1978 Aug; 25(4):355-9. PubMed ID: 710371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
    Hara I; Kataoka K; Tomita A; Takanohashi M; Nakane T; Kuwayama A; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):16-24. PubMed ID: 581754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of long-term treatment with bromocriptine on the growth hormone response to galanin in patients with acromegaly.
    Giustina A; Doga M; Bussi AR; Licini M; Schettino M
    Acta Endocrinol (Copenh); 1993 Feb; 128(2):131-5. PubMed ID: 7680832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients.
    Ferrari C; Paracchi A; Romano C; Gerevini G; Boghen M; Barreca A; Fortini P; Dubini A
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):467-76. PubMed ID: 2908102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
    Chiodini PG; Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Petroncini M; Liuzzi A; del Pozo E
    J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bromocriptine treatment of acromegaly.
    Cassar J; Mashiter K; Joplin GF
    Metabolism; 1977 May; 26(5):539-46. PubMed ID: 576725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response.
    Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):145-50. PubMed ID: 4038567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.
    Hartman ML; Pincus SM; Johnson ML; Matthews DH; Faunt LM; Vance ML; Thorner MO; Veldhuis JD
    J Clin Invest; 1994 Sep; 94(3):1277-88. PubMed ID: 8083369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the acute administration of haloperidol and pimozide on plasma GH levels in acromegaly.
    Carmina E; Lo Coco R; Lanzara P; Jannì A
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):609-15. PubMed ID: 115193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No effect of treatment with sodium valproate on plasma growth hormone in bromocriptine unresponsive acromegaly.
    Nortier JW; Croughs RJ; Schwarz F; Thijssen JH
    Acta Endocrinol (Copenh); 1986 Feb; 111(2):162-4. PubMed ID: 3082095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of growth hormone on sleep energy].
    Aström CP; Trojaborg W
    Ugeskr Laeger; 1994 Oct; 156(40):5849-52. PubMed ID: 7985277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests.
    Nortier JW; Croughs RJ; Thijssen JH; Schwarz F
    Clin Endocrinol (Oxf); 1984 May; 20(5):565-71. PubMed ID: 6744634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-alpha-ergocryptine.
    Camanni F; Massara F; Belforte L; Molinatti GM
    J Clin Endocrinol Metab; 1975 Mar; 40(3):363-6. PubMed ID: 1117050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of CB 154 in the treatment of acromegaly in France (author's transl)(proceedings)].
    Bricaire H
    Ann Endocrinol (Paris); 1976; 37(4):305-8. PubMed ID: 1037363
    [No Abstract]   [Full Text] [Related]  

  • 39. [125I]hGH metabolism in acromegaly: effects of chronic treatment with 2-Br-alpha-ergocryptine.
    Maneschi F; Navalesi R; Pilo A; Paci A
    J Clin Endocrinol Metab; 1978 Jul; 47(1):110-8. PubMed ID: 263286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An acromegalic patient with pulsatile secretion of growth hormone (GH) coincident with the slow-wave sleep.
    Matsuno M; Sohmiya M; Yamamoto H; Kato Y
    Endocr J; 1998 Oct; 45(5):687-92. PubMed ID: 10395250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.